Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 11712464 Intervention device
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
0
Current Assignee
Norwegian University of Science and Technology
0
Date Filed
July 20, 2020
0
Date of Patent
August 1, 2023
0
Patent Applicant
Norwegian University of Science and Technology
0
Patent Application Number
16933481
0
Patent Citations
US Patent 7896838 Illuminated syringe
0
US Patent 7981433 Targeted delivery of botulinum toxin to the sphenopalatine ganglion
0
US Patent 8123697 Method and apparatus for MR-guided biopsy
0
US Patent 8388600 Apparatus, system, and method for treating atypical headaches
0
US Patent 8795188 Device and method for a medical intervention
0
US Patent 8846622 Targeted delivery of botulinum toxin to the sphenopalatine ganglion
0
US Patent 9060794 System and method for robotic surgery
0
US Patent 9364230 Surgical stapling instruments with rotary joint assemblies
0
US Patent 9622832 Surgical instrument, in particular pointer instrument, comprising tip sensor
0
US Patent 8231588 Methods for ameliorating pain and devices for delivering a medicament
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
11712464
0
Patent Primary Examiner
May A Abouelela
0
CPC Code
A61M 2210/0687
0
A61K 38/4893
0
A61K 9/0019
0
A61B 10/0233
0
A61B 17/3403
0
A61B 2010/0208
0
A61B 2017/00199
0
A61B 2034/2051
0
A61B 2034/2055
0
A61B 2034/2068
0
•••
Find more entities like US Patent 11712464 Intervention device
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE